HomeCompareCTARF vs CL

CTARF vs CL: Dividend Comparison 2026

CTARF yields 160.00% · CL yields 2.43%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CTARF wins by $34.82M in total portfolio value
10 years
CTARF
CTARF
● Live price
160.00%
Share price
$1.25
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.86M
Annual income
$15,634,271.53
Full CTARF calculator →
CL
CL
● Live price
2.43%
Share price
$85.73
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.8K
Annual income
$5,401.96
Full CL calculator →

Portfolio growth — CTARF vs CL

📍 CTARF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCTARFCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CTARF + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CTARF pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CTARF
Annual income on $10K today (after 15% tax)
$13,600.00/yr
After 10yr DRIP, annual income (after tax)
$13,289,130.80/yr
CL
Annual income on $10K today (after 15% tax)
$206.23/yr
After 10yr DRIP, annual income (after tax)
$4,591.67/yr
At 15% tax rate, CTARF beats the other by $13,284,539.13/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CTARF + CL for your $10,000?

CTARF: 50%CL: 50%
100% CL50/50100% CTARF
Portfolio after 10yr
$17.45M
Annual income
$7,819,836.74/yr
Blended yield
44.82%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

CTARF
No analyst data
Altman Z
-25.2
Piotroski
4/9
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+7.8% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CTARF buys
0
CL buys
0
No recent congressional trades found for CTARF or CL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCTARFCL
Forward yield160.00%2.43%
Annual dividend / share$2.00$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28.6%
Portfolio after 10y$34.86M$40.8K
Annual income after 10y$15,634,271.53$5,401.96
Total dividends collected$32.40M$18.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: CTARF vs CL ($10,000, DRIP)

YearCTARF PortfolioCTARF Income/yrCL PortfolioCL Income/yrGap
1← crossover$26,700$16,000.00$11,012$312.01+$15.7KCTARF
2$68,494$39,925.23$12,196$412.95+$56.3KCTARF
3$169,010$95,720.83$13,599$549.66+$155.4KCTARF
4$401,580$220,739.56$15,288$736.64+$386.3KCTARF
5$919,872$490,181.40$17,353$995.28+$902.5KCTARF
6$2,033,632$1,049,369.50$19,926$1,357.80+$2.01MCTARF
7$4,344,139$2,168,152.23$23,194$1,873.82+$4.32MCTARF
8$8,976,727$4,328,498.22$27,439$2,621.52+$8.95MCTARF
9$17,964,357$8,359,258.83$33,088$3,727.38+$17.93MCTARF
10$34,856,133$15,634,271.53$40,806$5,401.96+$34.82MCTARF

CTARF vs CL: Complete Analysis 2026

CTARFStock

Centaurus Energy Inc., together with its subsidiaries, operates as an independent upstream oil and gas company in Argentina. The company explores, develops, and produces crude oil, natural gas liquids, and natural gas. Its primary producing concessions include Puesto Morales, El Surubi, and Coiron Amargo Sur Este. It also operates Palmar Largo, Santa Victoria, and El Chivil blocks. It holds approximately 950,000 net acres located in Argentina. The company was formerly known as Madalena Energy Inc. and changed its name to Centaurus Energy Inc. in September 2019. Centaurus Energy Inc. was incorporated in 2001 and is based in Calgary, Alberta.

Full CTARF Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this CTARF vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CTARF vs SCHDCTARF vs JEPICTARF vs OCTARF vs KOCTARF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.